AstraZeneca Sells Moderna Stake for Over USD 1 Billion
The report added that it was not clear when and over what period AstraZeneca sold its full holding in Moderna, Reuters reports.
AstraZeneca is to remain partners with Moderna when it comes to the production of treatments for other diseases and might sell its COVID-19 vaccine, developed with the Oxford University, on a commercial basis in the future if the virus becomes endemic, the report added.
Moderna, whose coronavirus vaccine was cleared for U.S. emergency use in December, last week said it was expecting USD 18.4 billion in sales from the vaccine this year, Reuters adds.
Naš izbor
Most Important News
06.04.2024. | Agriculture
Preconditions for Placement of Fresh Blueberries and Dried Plums in Chinese Market Secured
16.04.2024. | News
Jovan Ciric, Leasing Director Retail MPC Properties – MPC Echo symbolizes our desire for good ideas and innovative endeavors to spread freely and bring about positive changes
16.04.2024. | News
10.04.2024. | Finance, IT, Telecommunications, Tourism, Sports, Culture
Creative Industry – What This Serbian Economy Sector Worth EUR 2 Billion Encompasses
10.04.2024. | Finance, IT, Telecommunications, Tourism, Sports, Culture
18.04.2024. | Industry, Finance
Here come the new hunters for Serbian gold – Australian Strickland Metals buys mining project on mountain Rogozna
18.04.2024. | Industry, Finance
16.04.2024. | News
Economy Fair in Mostar opens – 26 companies from Serbia exhibiting
16.04.2024. | News
18.04.2024. | Transport
Jovanovic: Purchase of Siemens trams produced in Kragujevac for GSP Beograd should be considered
18.04.2024. | Transport